Debt (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 11, 2020 |
Nov. 30, 2020 |
Feb. 29, 2020 |
Sep. 30, 2019 |
Aug. 31, 2019 |
Oct. 31, 2018 |
May 31, 2018 |
May 31, 2017 |
Jun. 30, 2015 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Debt (Details) [Line Items] | |||||||||||
| Maintain minimum amount | $ 2,000,000 | ||||||||||
| Outstanding balance of note payable | $ 2,893,667 | $ 2,893,667 | |||||||||
| Purchase of shares (in Shares) | 1,666,667 | ||||||||||
| Exercisable and expire | In addition, the Company issued warrants to purchase up to 378,836 shares of Series B convertible preferred stock at a price of $2.88 per share with an initial aggregate fair value of $709,962 which are immediately exercisable and expire in September 2029. | The warrants have an exercise price of $96.24 per share and $106.17 per share, are immediately exercisable and expire in June 2025 and July 2027, respectively. | The warrant had an exercise price of $148.10 per share, was immediately exercisable and was to expire in July 2027. | ||||||||
| Maturity date description | the Company amended the Sub Agreement (“Amended Sub Agreement”) to extend the interest-only period through December 2020 and the maturity date to April 2023. Following the interest-only period, the Amended Sub Agreement requires 28 equal payments of principal and interest through March 2023, and a final lump sum payment of outstanding principal and interest at maturity. | Pursuant to the Sub Agreement, a final payment of $650,000 is payable at the maturity date in April 2023. | |||||||||
| Amortized discount | $ 105,739 | 327,138 | |||||||||
| Unamortized discount | 194,816 | 300,555 | |||||||||
| Fair value of warrant | $ 95,478 | 743,837 | 71,635 | ||||||||
| Cash proceeds | $ 3,303,535 | ||||||||||
| Maturity date | The notes accrued simple interest of 6% per year and, if not converted, were to mature in January 2020. | ||||||||||
| Interest expense | $ 1,078,769 | ||||||||||
| Outstanding balance | $ 2,180,300 | ||||||||||
| Warrant [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Purchase of shares (in Shares) | 91 | ||||||||||
| Warrant exercise price (in Dollars per share) | $ 106.17 | ||||||||||
| Common stock [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Purchase of shares (in Shares) | 666,667 | 10,000,000 | |||||||||
| Security agreement [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Borrowings amount | $ 3,500,000 | ||||||||||
| Interest rate | 3.62% | 5.25% | |||||||||
| Description of debt | The Agreement initially required monthly interest- only payments through December 2016, followed by 30 equal payments of principal and interest beginning January 2017 through its maturity in June 2019. However, the Agreement was amended multiple times, most recently in December 2020 and January 2021 to change the principal payment from a lump sum payment at December 31, 2020 to a 12-month amortization starting January 31, 2021 and be fully repaid on December 31, 2021. The Company must maintain at least $2,000,000 in an account with and under the control of the commercial bank, that reduces in line with the loan balance once the loan balance declines below $2,000,000. | ||||||||||
| Security agreement [Member] | Prime rate [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Interest rate | 0.50% | ||||||||||
| Sub Agreement [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Borrowings amount | $ 10,000,000 | ||||||||||
| Interest rate | 12.00% | 12.00% | |||||||||
| Purchase of shares (in Shares) | 3,376 | ||||||||||
| Warrant exercise price (in Dollars per share) | $ 148.10 | ||||||||||
| Maturity date | Pursuant to the Sub Agreement, a final payment of $650,000 is payable at the maturity date in April 2023. | ||||||||||
| Final payment | $ 650,000 | ||||||||||
| Legal cost | 279,757 | ||||||||||
| Amortized discount | 1,195,012 | ||||||||||
| Fair value of warrant | $ 265,255 | ||||||||||
| Convertible Promissory Notes [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Cash proceeds | $ 3,303,535 | ||||||||||
| Accrued interest rate | 0.06 | ||||||||||
| Gross proceeds | $ 14,700,000 | ||||||||||
| Percentage of conversion price | 90.00% | ||||||||||
| PPP Loan [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Interest rate | 1.00% | ||||||||||
| Description of debt | The PPP Loan matures in two years and bears interest at a rate of 1% per year, with all payments deferred through the six-month anniversary of the date of the PPP Loan. Principal plus accrued unpaid interest is to be paid in one payment two years after the date of this note and may be prepaid by the Company at any time prior to maturity without penalty. The Company may apply for forgiveness of amounts due under the PPP Loan, with the amount of potential loan forgiveness to be calculated in accordance with the requirements of the CARES Act based on payroll costs, any mortgage interest payments, any covered rent payments and any covered utilities payments during the 8-24 week period after the origination date of the Loan. | ||||||||||
| Principal amount | $ 2,180,300 | ||||||||||
| Outstanding balance | $ 2,180,300 | ||||||||||
| Commercial bank [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Maintain minimum amount | $ 2,000,000 | ||||||||||
| Purchase of shares (in Shares) | 234 | ||||||||||
| Warrant exercise price (in Dollars per share) | $ 96.24 | ||||||||||
| Series A-2 [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Purchase of shares (in Shares) | 3,376 | ||||||||||
| Series B convertible preferred stock [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Purchase of shares (in Shares) | 580,383 | 12,576 | 580,383 | ||||||||
| Warrant exercise price (in Dollars per share) | $ 2.88 | $ 2.88 | |||||||||
| Fair value of warrant | 709,962 | ||||||||||
| Principal amount | $ 15,748 | ||||||||||
| Converted shares (in Shares) | 1,281,631 | ||||||||||
| Price per share (in Dollars per share) | $ 2.88 | ||||||||||
| Series B convertible preferred stock [Member] | Common stock [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Purchase of shares (in Shares) | 378,836 | 378,836 | |||||||||
| Price per share (in Dollars per share) | $ 2.88 | ||||||||||
| Series A-1 convertible preferred stock [Member] | |||||||||||
| Debt (Details) [Line Items] | |||||||||||
| Purchase of shares (in Shares) | 100,712 | ||||||||||
| Warrant exercise price (in Dollars per share) | $ 4.76 | ||||||||||